Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Formalin-induced pain increases testosterone breakdown in the rat brain and spinal cord.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Finasteride reduces hair loss by blocking testosterone's effects on scalp cells.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Tanshinone compounds can help prevent hair loss caused by testosterone.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

JAK inhibition reduces autoimmune issues in Down syndrome.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Some gonadal hormone drugs can block filovirus entry into cells.